Kiniksa Pharmaceuticals（納斯達克代碼：KNSA）報告季度每股虧損$(0.12)，低於分析師一致預期的$0.04，下降了400%。去年同期每股收益爲$0.35，同比下降了134.29%。公司報告季度銷售額爲$1.2254億，未達到分析師一致預期的$1.2338億，同比下降了0.68%。去年同期銷售額爲$8339萬，同比增長了46.93%。

以上內容來自Benzinga Earnings專欄，原文如下：

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.04 by 400 percent. This is a 134.29 percent decrease over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $122.54 million which missed the analyst consensus estimate of $123.38 million by 0.68 percent. This is a 46.93 percent increase over sales of $83.39 million the same period last year.